Baird Maintains Outperform on AdaptHealth, Lowers Price Target to $9
Baird analyst Eric Coldwell maintains AdaptHealth (NASDAQ:AHCO) with a Outperform and lowers the price target from $10 to $9.
Stocks · News reference
Crude Oil Down Over 5%; McDonald's Earnings Top Views
U.S. stocks gain with Nasdaq up more than 2% on Tuesday. Dow up 1.79% to 54,129.35, Nasdaq up 2.22% to 26,490.24, S&P 500 up 1.64% to 7,725.48. Tech shares jump 3.8%, utilities down 0.5%. McDonald's beats earnings estimates. Ibotta, Backblaze, Corvex up, Adapthealth, Better Home & Finance, Clearpoint Neuro down.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
AdaptHealth shares are trading lower. The company appointed Harriss T. Currie as its Chief Financial Officer.
AdaptHealth Corp. Appoints Harriss T. Currie CFO, Effective Sept. 9, Succeeding Jason Clemens
UBS Maintains Buy on AdaptHealth, Lowers Price Target to $10
UBS analyst Kevin Caliendo maintains AdaptHealth (NASDAQ:AHCO) with a Buy and lowers the price target from $14 to $10.
UPDATE: Better Home & Finance Founder Vishal Garg Says Egan-Jones Recommends Shareholders Vote For Proposals To Remove Five Directors From Board; Sets October 2 Consent Target Date
Securities Fraud Investigation Into Better Home & Finance Holding Company (BETR) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
The Law Offices of Frank R. Cruz is investigating Better Home & Finance Holding Company for potential federal securities law violations. The company's stock fell 28.5% on May 7, 2026, after missing its $1.0 billion monthly funded loan volume target, and dropped another 36.56% on August 4, 2026, following the abrupt CEO change from founder Vishal Garg to interim CEO Daniel Lewis.